Development of resistance in Pseudomonas aeruginosa obtained from patients with cystic fibrosis at different times

This publication has 19 references indexed in Scilit:

• Epidemiologic characterization of Pseudomonas aeruginosa in patients with cystic fibrosis
  Clinical Microbiology & Infection, 2000
• Molecular Mechanisms of Fluoroquinolone Resistance in Pseudomonas aeruginosa Isolates from Cystic Fibrosis Patients
  Antimicrobial Agents and Chemotherapy, 2000
• Activities of Tobramycin and Six Other Antibiotics against Pseudomonas aeruginosa Isolates from Patients with Cystic Fibrosis
  Antimicrobial Agents and Chemotherapy, 1999
• Multiresistant non-fermentative Gram-negative bacteria in cystic fibrosis patients: the results of an Italian multicenter study
  European Journal of Epidemiology, 1999
• Comparison of the antibacterial activities of the quinolones Bay 12- 8039, gatifloxacin (AM 1155), trovafloxacin, clinafloxacin, levofloxacin and ciprofloxacin [published erratum appears in J Antimicrob Chemother 1998 Jun;41(6):672]
  Journal of Antimicrobial Chemotherapy, 1997
• Oral ciprofloxacin vs. intravenous ceftazidime plus tobramycin in pediatric cystic fibrosis patients: comparison of antipseudomonas efficacy and assessment of safety with ultrasonography and magnetic resonance imaging
  The Pediatric Infectious Disease Journal, 1997
• Development of antibiotic resistance in Pseudomonas aeruginosa during two decades of antipseudomonal treatment at the Danish CF Center
  APMIS, 1994
• Emergence of antibiotic resistance amongst Pseudomonas aeruginosa isolates from patients with cystic fibrosis
  Journal of Antimicrobial Chemotherapy, 1993
• Role of alginate in infection with mucoid Pseudomonas aeruginosa in cystic fibrosis.
  Thorax, 1992
• Identification of the Cystic Fibrosis Gene: Genetic Analysis
  Science, 1989